This article discusses the importance and effectiveness of viscoelastic hemostatic assays
(VHAs) in assessing hemostatic competence and guiding blood component therapy (BCT) in …

Preeclampsia and peripartum cardiomyopathy (PPCM) are significant obstetric problems
that can arise during or after pregnancy. Both are known to be causes of maternal mortality …

Background Gestational diabetes mellitus (GDM) is a common pregnancy complication
associated with adverse outcomes including preeclampsia, caesarean section, macrosomia …

Objectives Preeclampsia (PE) is a serious complication of pregnancy. The fibrinolytic system
play crucial roles regarding placentation and evolution of PE. Aim To study comprehensively …

Background: To identify potential biomarkers in the 1st trimester of pregnancy for the
identification of women destined to develop early onset preeclampsia (EOPE). Methods …

Plasminogen activator inhibitor type 1 (PAI-1) is a main inhibitor of fibrinolysis. The PAI-1
gene (SERPINE1) harbors genetic variants with the potential of modifying plasma levels of …

This present study was designed to investigate the effects of alpha-1-antitrypsin (AAT) on
oxidative stress in preeclampsia (PE) by regulating p38 mitogen-activated protein kinase …

Gestational diabetes mellitus (GDM) increases the risk of hypertensive disorders of
pregnancy (HDP). We aimed to analyze the altered inflammatory markers and angiogenic …

We hypothesize that first trimester circulating micro particle (CMP) proteins will define
preeclampsia risk while identifying clusters of disease subtypes among cases. We …

Hypertensive disorders complicating pregnancy can be classified as gestational
hypertension, mild preeclampsia, and severe preeclampsia. It is necessary to evaluate and …